Summary

“The Future of the Global Refining Industry to 2015 – Benefiting From National Oil Companies’ Growth” is an essential source for top-level energy industry information and analyses. The report provides an in-depth analysis of the key trends, issues, challenges in the global refining industry to 2015. It also gives information on refinery product types and future refining trends. The research covers the global refining market with information on historical and forecast capacities of refineries by region and key countries during the period 2000-2015. Leading companies in the global refining industry and their investment opportunities and challenges have been examined in the report.

Scope

- The report provides detailed information and analysis on refining capacities by region and leading countries, upcoming refineries and capacity expansions, market shares of key companies and competitive scenario in the global refining market to 2015
- Global refining industry growth, capacity additions through new and existing refineries, global petroleum products demand and key global refining industry trends, drivers and challenges are covered in the report
- Its scope includes information on petroleum products consumption (2009), refinery wise capacity (2000-2015), competitive overview(2009) in 14 major markets across the globe including China, Japan, India, Russian Federation, Germany, Italy, United States, Canada, Saudi Arabia, Iran (Islamic Republic of), Kuwait, Brazil, Mexico and Venezuela
- Analysis of key issues and challenges for refiners in Asia-Pacific, Europe, Middle East and Africa, North America, South and Central America between 2010 and 2015
- Refinery throughputs and utilization rates (2000-2008), details of key upcoming refinery projects (2010-2015) and competitive scenario (2009) of all the five regions across the globe
- Global refining margin trends in the US Gulf Coast, the US West Coast, the US East Coast, North West Europe and Singapore markets between 2004 and 2009
- Provides information on refining capacities (2000-2015), planned and active refineries directly owned (2000-2015) by top 10 global refiners including ExxonMobil Corporation, China Petroleum & Chemical Corporation, Royal Dutch Shell Plc, ConocoPhillips, Petrochina Company Ltd, Valero Energy Corporation, BP Plc, Total SA, Petroleo Brasileiro SA and Petroleos De Venezuela SA

Reasons to buy

- The report will enhance your decision making capability in a more rapid and time sensitive manner.
- The research will allow you to identify prospective investment targets through a comprehensive update and discussion on new refinery additions and capacity expansions of existing refineries across the globe.
- Find the most attractive investment destination(s) for your business by comparing regional industries in Asia Pacific, Europe, North America, Middle East and Africa and South and Central America.
- Understand the threats and opportunities in the global refining industry and fine tune strategies to exploit the underlying trends
- Understand the changing demand for oil products to anticipate and create products ahead of the competition.
- Be well prepared to operate in the era of price volatility by understanding the impact of changing prices on refined products and refinery margins.
- Benchmark yourself against major refining companies globally by leveraging on our detailed company analysis.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1477/The-Future-Of-The-Global-Refining-Industry-to-2015-%E2%80%93-Benefiting-From-National-Oil-Companies%E2%80%99-Growth.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

“The Future of the Offshore Drilling Industry to 2015 – Market Analysis, Capital Spend and Competitive Landscape” The study, which is an offering from the company’s Energy Research Group, provides an in-depth analysis of the offshore drilling industry and highlights the various concerns, shifting trends and emerging regions in the global offshore drilling industry. The report provides forecasts of the offshore exploratory and development drilling expenditure to 2015. The report provides in-depth analysis of the key trends and challenges in the global drilling industry. The report also discusses the major offshore projects globally and provides an analysis of the competitive scenario in each of the geographies covered. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

The global offshore drilling market experienced a slowdown in 2009 following the hectic activity witnessed in the previous years. The growth of the offshore drilling market is driven by high demand and the prices of crude oil and natural gas. The increase in the demand for oil and natural gas due to high economic growth during the period from 2004 to 2008 was responsible for the continuous increase of crude oil and natural gas prices until mid 2008. The demand for oil and gas and the prevalent high prices stimulated increased activity in the offshore drilling market. However, since the economic slowdown and the collapse of the oil and gas prices from the record levels of 2008, many of the offshore projects have become uneconomical and have since been delayed or cancelled. Also, offshore drilling expenditure is directly dependent on the exploration and production capital spending of the international oil companies, national oil companies and independent producers. The tight credit situation and an uncertain outlook for the oil and gas global demand have affected the capital expenditure plans of the exploration and production companies. These factors have had a negative effect on the offshore drilling expenditure in 2009. However, the future outlook for offshore drilling is encouraging and the expenditure is expected to steadily increase to 2015.

Scope

- Provides a complete overview of the future prospects of the offshore drilling business.
- Provides forecasts of the offshore drilling expenditure to 2015.
- Includes the exploratory and development drilling expenditure forecasts to 2015
- Analyzes the offshore drilling expenditure in the major regions of the world.
- Forecasts the world market by region and type of activity in terms of expenditure levels.
- Identifies the high growth areas and markets for the future business expansion and market expansion.
- in-depth analysis of the offshore drilling industry, highlights the various concerns, shifting trends and emerging regions in the global offshore drilling industry
- Analyzes the strategies of the major offshore drilling contractors such as Transocean Ltd, Noble Corporation, Diamond Offshore, Ensco International plc, Seadrill
- Top lease holders discussed include BP Plc, Anadarko Petroleum Corporation, Hess Corporation,ExxonMobil Corporation,Petroleo Brasileiro S.A., Repsol YPF, S.A

Reasons to buy

- Develop business strategies with the help of specific insights about the offshore drilling industry.
- Identify opportunities and challenges in the global offshore drilling industry.
- Understand the market positioning of the offshore drilling contractors.
- Increase future revenues and profitability with the help of insights on the future opportunities
- Critical success factors in the global offshore drilling industry.
- Benchmark your operations and strategies against the major players in the global offshore drilling industry.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1476/The-Future-of-the-Offshore-Drilling-Industry-to-2015-Market-Analysis-Capital-Spend-and-Competitive-Landscape.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

“The Future of the Neurology Devices Market to 2016 – Market Forecasts, Competitive Landscape and Pipeline Analysis” provides key data, information and analysis on the global neurology devices market, a key segment within the medical device industry. This medical device report provides market landscape, competitive landscape and market trends information on five neurology devices market categories – CSF Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for five neurology devices market categories – Cerebro Spinal Fluid (CSF) Management, Neurosurgical Products, Neurostimulation Devices, Interventional Neurology and Radiosurgery.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the neurology devices market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Boston Scientific, Cordis, St. Jude Medical, Cyberonics, ev3, Elekta, Accuray, B. Braun, and Codman & Shurtleff.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the neurology devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the neurology devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global neurology devices market and the factors shaping it.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1478/The-Future-of-the-Neurology-Devices-Market-to-2016-%E2%80%93-Market-Forecasts-Competitive-Landscape-and-Pipeline-Analysis.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

Nuclear industry plays a vital role in global power generation. As the demand for nuclear power generation has been growing worldwide, nuclear fuel industry gains significant attention. ‘The Future of Global Nuclear Fuel Processing Industry to 2020’ provides in-depth analysis and forecast of nuclear fuel processing industry. The reemergence of nuclear industry in the global energy arena indicates a significant growth of nuclear fuel processing industry.
Scope

- Analyzes the growth of the global nuclear fuel processing industry and the estimated demand for uranium conversion, enrichment and fabrication services in various key regions including Europe, Asia Pacific, North America, Central and South America, and the Middle East and Africa.
- Explores the growth drivers for the nuclear fuel processing industry in the major nuclear power producing countries.
- Analyzes the trends in the global nuclear fuel processing industry and the opportunities and key challenges in the market for processed fuel.
- Annualized market data for uranium conversion, enrichment and fabrication services from 2009, and forecasts to 2020 are included in this research.
- Regional growth analysis of the total nuclear fuel processing market broken down by segment.
- Qualitative analysis of the market drivers, restraints, future outlook, and challenges by categories and segments.
- Analyzes the key market players in different categories such as uranium conversion, enrichment and fuel fabrication and market share information for leading companies such as Areva, Urenco, USEC Inc and TVEL.

Reasons to buy

- Obtain the difficult to find information and analysis regarding the fuel processing industry.
- Gain the most up to date information and analysis on the potential opportunities and challenges in the global nuclear fuel processing industry.
- Identify the key regions with potential opportunities for the nuclear fuel processing market.
- Understand the emerging opportunities for processed nuclear fuel across various geographies.
- Gain information on key market players and their positions in the global nuclear fuel processing industry
- Be informed about the key industry activities and investments and strategic consolidations and their effect on the global market opportunities
- Understand the potential market opportunities in various geographies and fine tune your business strategy in target locations

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/2146/The-Future-of-the-Global-Nuclear-Fuel-Processing-Industry-to-2020.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

Summary

“The Future of the Middle East Power Market to 2020: Opportunity Analysis, Technology Overview, Infrastructure and Policy Assessment”" analyzes the power market in the middle east countries. The Middle East region has become an investment hub for utility and construction companies. With the growing economy, there has been an increasing demand for power and hence has resulted in plans for the boost in power generation. Though oil and gas has been the primary source of power in this region, but renewable energy is also making in-roads in some of the nations in the region.

Scope

- The report covers Jordan, Iraq, Iran, Kuwait, Syria, Bahrain, Oman, Lebanon, Qatar, and Yemen
- Provides analysis of import, export, regulatory and infrastructure of the power sector in the top 10 countries.
- Detailed forecast of installed capacity by thermal, hydro, renewable and nuclear sources in each of the top 10 countries till 2020.
- Detailed forecast of generation by thermal, hydro, renewable and nuclear sources till 2020.
- The report provides details of active and upcoming plants in the country.
- It details the major companies like Saudi Electricity Company (SEC), Marafiq (Yanbu), Saline Water Conversion Corporation (SWCC), Rabigh Arabian Water & Electricity Company, Tavanir, TAQA, DEWA, SEWA, FEWA, Central Electricity Generating Company (CEGCO), Qatar Electricity & Water Company and their SWOT analysis.
- It discusses the major trends, drivers and challenges in the overall industry.

Reasons to buy

- Identify key markets and investment opportunities for foreign investors in Power Sector in the Middle East.
- Facilitate decision-making based on strong historical and forecast data and elaborate growth opportunities analysis.
- Understand and respond to the regulatory and foreign investment structure in the country.
- Position yourself to gain the maximum advantage of the top 10 Middle East power market’s growth potential.

Companies Mentioned

Saudi Electricity Company
Tavanir
Qatar Electricity & Water Company Q.S.C
Abu Dhabi National Energy Company PJSC
Dubai Electricity and Water Authority
GDF SUEZ Energy International
Electricity & Water Authority
Ministry of Electricity of Iraq

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1965/The-Future-of-the-Middle-East-Power-Market-to-2020-Opportunity-Analysis-Technology-Overview-Infrastructure-and-Policy-Assessment.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of High Potency Active Pharmaceutical Ingredients (HPAPIs), Market Forecasts and Growth Opportunities to 2015 – Growing Demand Drives Investment in Capacity”. The study, which is an offering from the company’s Chemicals Research Group, provides in-depth analysis of the global HPAPIs market with revenue forecasts up to 2015. Revenue forecasts, which include historical statistics of the market, are provided for the major regions – Europe, North America and Asia Pacific. The factors that drive and restrain the growth of the HPAPIs market are also analyzed in the report. In addition, the research provides market share analysis of the leading HPAPIs producers for major regions. The market for HPAPIs is also analyzed based on the product types and therapeutic applications at a global level. The report is built using the data and information sourced from proprietary databases, primary and secondary research and in house analysis by GBI Research’s team of industry experts.

Scope

- HPAPIs market revenues data from 2005 to 2009 and forecast for six years to 2015.
- HPAPIs in key regions – Europe, North America and Asia Pacific.
- Coverage of the product types and therapeutic applications of the global HPAPIs market.
- Drivers such as increasing demand due to the growth in better targeted drugs and restraints such as the economic recession for the global market as well as for the regional markets.
- Information on the competitive landscape with the revenue shares of the leading companies in the major regions of the world such as Sigma Aldrich, Bristol Myers Squibb, Sanofi Aventis, Carbogen Amcis and Novasep.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the global HPAPIs market.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key companies best positioned to take advantage of the emerging market opportunities.
- Benchmark different geographies by the historic and forecasted growth of the HPAPIs market.
- Identify macro and micro-economic trends shaping and driving the global HPAPIs market.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1964/The-Future-of-High-Potency-Active-Pharmaceutical-Ingredients-HPAPIs-Market-Forecasts-and-Growth-Opportunities-to-2015-Growing-Demand-Drives-Investment-in-Capacity.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of the Home Healthcare Equipment Market to 2016 – Increasing Awareness Driving Demand” provides key data, information and analysis on the global home healthcare equipment market. The report provides market landscape, competitive landscape and market trends information on seven home healthcare equipment market segments – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape, key pipeline products and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by team of industry experts.

Scope

- Key geographies covered include the US (United States), Canada, the UK (United Kingdom), Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Market size and company share data for seven home healthcare equipment market categories – glucose monitoring systems, insulin delivery devices, inhalation systems, hematology rapid tests, automatic sphygmomanometers and remote patient monitoring.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2008
- Qualitative analysis of key market trends, market drivers, and restraints by each category within the home healthcare equipment market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the home healthcare equipment market globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What’s the next being thing in the home healthcare equipment market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global home healthcare equipment market and the factors shaping it.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1955/The-Future-of-the-Home-Healthcare-Equipment-Market-to-2016-Market-Forecasts-Competitive-Landscape-and-Pipeline-Analysis.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of Blood Disorders Therapeutics, Analysis and Market Forecasts to 2016 – Better and More Cost-Effective Treatment Options Create Opportunities”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global blood disorders market. The report analyzes the markets for blood disorders in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets

Scope

The scope of this report includes:
- Annualized market data for the blood disorders market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments including anemia, thrombosis, hemophilia, neutropenia and thrombocytopenia
- Analysis of the blood disorders market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the blood disorders market including market size, annual cost of therapy, sales volume and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are Amgen, Inc., Sanofi-Aventis, Bristol-Myers Squibb, Centocor Ortho Biotech Inc., and Baxter.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global blood disorders market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

Amgen
Sanofi-Aventis
Bristol-Myers Squibb
Centocor Ortho Biotech Inc
Baxter

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1963/The-Future-of-Blood-Disorders-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Better-and-More-Cost-Effective-Treatment-Options-Create-Opportunities.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of Dermatology Therapeutics, Analysis and Market Forecasts to 2016 – Increasing Prescription Rate to Drive Revenues”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global dermatology therapeutics market. The report analyzes the markets for dermatology therapeutics in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns and sales are forecast until 2016 for the key geographies as well as select therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and also analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Annualized market data for the dermatology therapeutics market from 2001 to 2009, forecast forward to 2016
- Analysis of the leading therapeutic segments. These include Acne, Psoriasis, Dermatitis, Rosacea and Skin diseases.
- Analysis of the dermatology therapeutics market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain, and Japan
- Market characterization of the dermatology therapeutics market including market size, annual cost of therapy, and treatment usage patterns
- Key drivers and barriers that have a significant impact on the market
- Coverage of pipeline molecules in various phases of drug development
- Competitive benchmarking of leading companies. The key companies studied in this report are F.Hoffmann-La Roche, GlaxoSmithKline, Leo Pharma, Sanofi-Aventis, Genentech, Novartis AG, Johnson & Johnson, Galderma Pharma SA, and Merck & Co, Inc.
- Key M&A activities, licensing agreements, that have taken place between 2008 and 2009 in the global dermatology therapeutics market

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

GlaxoSmithKline plc (GSK)
Johnson & Johnson
Bayer AG
Merck & Co., Inc
Novartis AG
Sanofi-Aventis
LEO Pharma A/S
F. Hoffmann-La Roche Ltd
L’Oreal
Galderma S.A
Nestle S.A.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1962/The-Future-of-Dermatology-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Increasing-Prescription-Rate-to-Drive-Revenues.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com

“The Future of Pain Management Therapeutics, Analysis and Market Forecasts to 2016 – Increasing Generic Competition Creates Challenges”. The report provides in-depth analysis of unmet needs, drivers and barriers that impact the global pain management therapeutics market. The report analyzes the markets for pain management in the US, the top five countries in Europe (the UK, Germany, France, Italy and Spain) and Japan. Treatment usage patterns, sales, price and volume are forecast until 2016 for the key geographies as well as the leading therapeutic segments. Further, the report provides competitive benchmarking for the leading companies and analyzes the mergers, acquisitions and licensing agreements that shape the global markets. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.

Scope

The scope of this report includes:
- Annualized market data for the pain management market from 2001 to 2009, forecast forward to 2016.
- Analysis of the leading therapeutic segments, including neuropathic pain, osteoarthritis, cancer pain, migraine and fibromyalgia.
- Analysis of the pain management market in the leading geographies of the world, which include the US, the UK, Germany, France, Italy, Spain and Japan.
- Market characterization of the pain management market including market size, the annual cost of therapy, sales volume and treatment usage patterns.
- Key drivers and barriers that have a significant impact on the market.
- Coverage of pipeline molecules in the various phases of drug development.
- Competitive benchmarking of leading companies. The key companies studied in this report are Pfizer, Inc., Eli Lilly and Company, Johnson & Johnson, Novartis AG, Merck & Co Inc., and Cephalon, Inc.
- Key M&A activities that have taken place in 2009 and the licensing agreements in the 2008-2009 global pain management market.

Reasons to buy

The report will enhance your decision making capability. It will allow you to
- Align product portfolio to the markets with high growth potential
- Develop market-entry and market expansion strategies by identifying the leading therapeutic segments and geographic markets poised for strong growth
- Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety
- Develop key strategic initiatives by understanding key focus areas of leading companies
- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps

Companies Mentioned

Pfizer, Inc.
Eli Lilly and Company
Johnson & Johnson
Endo Pharmaceuticals
Novartis AG
Merck & Co Inc
Cephalon, Inc.

To know more about this report & to buy a copy please visit :
http://www.visionshopsters.com/product/1961/The-Future-of-Pain-Management-Therapeutics-Analysis-and-Market-Forecasts-to-2016-Increasing-Generic-Competition-Creates-Challenges.html

Contact us:

Visionshopsters
Ph : 91-22-40583000
Emailid: marketing@visionshopsters.com
Website : www.visionshopsters.com